BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25636474)

  • 1. Methods to generate genetically engineered mouse models of soft tissue sarcoma.
    Dodd RD; Añó L; Blum JM; Li Z; Van Mater D; Kirsch DG
    Methods Mol Biol; 2015; 1267():283-95. PubMed ID: 25636474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus.
    Douchi D; Yamamura A; Matsuo J; Melissa Lim YH; Nuttonmanit N; Shimura M; Suda K; Chen S; Pang S; Kohu K; Abe T; Shioi G; Kim G; Shabbir A; Srivastava S; Unno M; Bok-Yan So J; Teh M; Yeoh KG; Chuang LSH; Ito Y
    Gastroenterology; 2021 Dec; 161(6):1907-1923.e26. PubMed ID: 34391772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia.
    Yang X; La Rosa FG; Genova EE; Huber K; Schaack J; Degregori J; Serkova NJ; Li Y; Su LJ; Kessler E; Flaig TW
    PLoS One; 2013; 8(9):e74809. PubMed ID: 24058630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injury promotes sarcoma development in a genetically and temporally restricted manner.
    Van Mater D; Xu E; Reddy A; Añó L; Sachdeva M; Huang W; Williams N; Ma Y; Love C; Happ L; Dave S; Kirsch DG
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis.
    Zhang M; Kirsch DG
    Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A spatially and temporally restricted mouse model of soft tissue sarcoma.
    Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
    Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mouse models for human colorectal cancer with liver metastasis].
    Huang XD; Zheng YB; Yang YJ; Yang C; Li HL; Cheng HR
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(34):2701-2705. PubMed ID: 31505723
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical use of advanced mouse models for lung cancer.
    Safari R; Meuwissen R
    Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
    Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
    PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
    Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
    J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
    Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
    Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse model expressing P53(R172H), luciferase, EGFP, and KRAS(G12D) in a single open reading frame for live imaging of tumor.
    Ju HL; Calvisi DF; Moon H; Baek S; Ribback S; Dombrowski F; Cho KJ; Chung SI; Han KH; Ro SW
    Sci Rep; 2015 Jan; 5():8053. PubMed ID: 25623590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
    Choi J; Curtis SJ; Roy DM; Flesken-Nikitin A; Nikitin AY
    Am J Pathol; 2010 Nov; 177(5):2645-58. PubMed ID: 20864684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
    Tang FH; Hsieh TH; Hsu CY; Lin HY; Long CY; Cheng KH; Tsai EM
    Int J Cancer; 2017 Apr; 140(8):1860-1869. PubMed ID: 28032649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal Squamous Cell Carcinoma Develops in Mice with Conditional Arid1a Loss and Gain of Oncogenic Kras Driven by Progesterone Receptor Cre.
    Wang X; Praça MSL; Wendel JRH; Emerson RE; DeMayo FJ; Lydon JP; Hawkins SM
    Am J Pathol; 2021 Jul; 191(7):1281-1291. PubMed ID: 33882289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.
    Raimondi AR; Molinolo A; Gutkind JS
    Cancer Res; 2009 May; 69(10):4159-66. PubMed ID: 19435901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of primary tumors with Flp recombinase in FRT-flanked p53 mice.
    Lee CL; Moding EJ; Huang X; Li Y; Woodlief LZ; Rodrigues RC; Ma Y; Kirsch DG
    Dis Model Mech; 2012 May; 5(3):397-402. PubMed ID: 22228755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.